Search research articles
Contact Us
Filters
Showing results (201-210 of 480) with videos related to
Page
of 48
Sort By:
Addiction Biology
|
July 15, 2010
Association of ADH4 genetic variants with alcohol dependence risk and related phenotypes: results from a larger multicenter association study
Ulrich W Preuss, Monika Ridinger, Dan Rujescu, et al.
Journal of Affective Disorders
|
February 1, 2026
Prognostic implications of social anxiety comorbidity in major depressive disorder. Evidence from three large samples with adult and older patients
Paolo Olgiati, Maria Luca, Antonina Luca, et al.
The International Journal of Neuropsychopharmacology
|
October 12, 2021
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 15, 2019
Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples
Stefano Porcelli, Siegfried Kasper, Joseph Zohar, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
September 17, 2014
Auditory verbal hallucinations and the interhemispheric auditory pathway in chronic schizophrenia
Marlene Wigand, Marek Kubicki, Christian Clemm von Hohenberg, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
June 23, 2026
Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry
Maximilian Preiss, Valentin Popper, Luna Helene Charlotte Faber, et al.
Journal of Affective Disorders
|
June 12, 2022
The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs
Gernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
July 11, 2008
Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia
Rainald Mössner, Anna Schuhmacher, Svenja Schulze-Rauschenbach, et al.
Schizophrenia Research
|
September 6, 2011
Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia
Olaoluwa Okusaga, Patricia Langenberg, Aamar Sleemi, et al.
Neuroimage
|
February 6, 2015
Interaction between 5-HTTLPR and 5-HT1B genotype status enhances cerebral 5-HT1A receptor binding
Pia Baldinger, Christoph Kraus, Christina Rami-Mark, et al.
Page
of 48
Search research articles
Search
Showing results (201-210 of 480) with videos related to
Sort By:
Page
of 48
Addiction Biology
|
July 15, 2010
Association of ADH4 genetic variants with alcohol dependence risk and related phenotypes: results from a larger multicenter association study
Ulrich W Preuss, Monika Ridinger, Dan Rujescu, et al.
Journal of Affective Disorders
|
February 1, 2026
Prognostic implications of social anxiety comorbidity in major depressive disorder. Evidence from three large samples with adult and older patients
Paolo Olgiati, Maria Luca, Antonina Luca, et al.
The International Journal of Neuropsychopharmacology
|
October 12, 2021
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 15, 2019
Social dysfunction in mood disorders and schizophrenia: Clinical modulators in four independent samples
Stefano Porcelli, Siegfried Kasper, Joseph Zohar, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
September 17, 2014
Auditory verbal hallucinations and the interhemispheric auditory pathway in chronic schizophrenia
Marlene Wigand, Marek Kubicki, Christian Clemm von Hohenberg, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
June 23, 2026
Real-world effectiveness and safety of intranasal esketamine for treatment-resistant depression: data from the enTRD registry
Maximilian Preiss, Valentin Popper, Luna Helene Charlotte Faber, et al.
Journal of Affective Disorders
|
June 12, 2022
The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs
Gernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
July 11, 2008
Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia
Rainald Mössner, Anna Schuhmacher, Svenja Schulze-Rauschenbach, et al.
Schizophrenia Research
|
September 6, 2011
Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia
Olaoluwa Okusaga, Patricia Langenberg, Aamar Sleemi, et al.
Neuroimage
|
February 6, 2015
Interaction between 5-HTTLPR and 5-HT1B genotype status enhances cerebral 5-HT1A receptor binding
Pia Baldinger, Christoph Kraus, Christina Rami-Mark, et al.
Page
of 48